Cases 41 - 50 of 584
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 1:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PETRIE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01772
Plaintiff:
STEVEN PETRIE
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ESTATE OF KORENE HUNGATE v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01377
Plaintiff:
KARLYN HUNGATE and ESTATE OF KORENE HUNGATE
Defendant:
AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, AUROLIFE PHARMA, LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DAWSON v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv01159
Plaintiff:
DIANA DAWSON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAUSCH HEALTH IRELAND LIMITED et al v. AUROBINDO PHARMA LIMITED et al
as 2:2023cv00170
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED and SALIX PHARMACEUTICALS, INC.
Defendant:
AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA INC. and AURO PEPTIDES LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CHIESI USA INC. et al v. EUGIA PHARMA SPECIALITIES LIMITED et al
as 1:2023cv00022
Defendant:
EUGIA PHARMA SPECIALITIES LIMITED, EUGIA PHARMA SPECIALTIES LIMITED, EUGIA US LLC and others
Plaintiff:
CHIESI USA INC. and CHIESI FARMACEUTICI S.P.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
as 2:2023cv00926
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
WRIGLEY v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00831
Plaintiff:
BYRON WRIGLEY
Defendant:
AUROBINDO PHARMA, LTD., HETERO DRUGS, LTD., HETERO LABS, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
as 1:2019md02875
Defendant:
TEVA INDUSTRIES LTD., HETERO USA INC., CAMBER PHARMACEUTICALS INC. and others
Plaintiff:
DOMINIC STIMMA, JYNONA GAIL LEE, MARGOTH STRAND and others
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
HALE et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv00575
Plaintiff:
WILEY HALE and STARRTRYNEA REEVES
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
